Insider Trading Activity NxStage Medical, Inc. (NASDAQ:NXTM) – SVP Sold 4,300 shares of Stock

ME Staff
-
0

Insider Trading Activity For NxStage Medical, Inc. (NASDAQ:NXTM)

Matthew W Towse , SVP of NxStage Medical, Inc. (NASDAQ:NXTM) reportedly Sold 4,300 shares of the company’s stock at an average price of 24.16 for a total transaction amount of $103,888.00 SEC Form

Insider Trading History For NxStage Medical, Inc. (NASDAQ:NXTM)

  • On 11/2/2012 David S Utterberg, Director, sold 34,730 with an average share price of $11.13 per share and the total transaction amounting to $386,544.90.View SEC Filing
  • On 11/13/2012 David S Utterberg, Director, sold 184,204 with an average share price of $11.58 per share and the total transaction amounting to $2,133,082.32.View SEC Filing
  • On 5/13/2013 Thomas Shea, SVP, sold 15,724 with an average share price of $12.67 per share and the total transaction amounting to $199,223.08.View SEC Filing
  • On 6/10/2013 Thomas Shea, SVP, sold 5,000 with an average share price of $13.73 per share and the total transaction amounting to $68,650.00.View SEC Filing
  • On 7/8/2013 Thomas Shea, SVP, sold 7,000 with an average share price of $14.34 per share and the total transaction amounting to $100,380.00.View SEC Filing
  • On 8/12/2013 Thomas Shea, SVP, sold 1,172 with an average share price of $12.93 per share and the total transaction amounting to $15,153.96.View SEC Filing
  • On 9/9/2013 Thomas Shea, SVP, sold 1,000 with an average share price of $12.30 per share and the total transaction amounting to $12,300.00.View SEC Filing

    • Analyst Ratings For NxStage Medical, Inc. (NASDAQ:NXTM)
    These are 1 Hold Rating, 4 Buy Ratings .
    The current consensus rating for NxStage Medical, Inc. (NASDAQ:NXTM) is Buy (Score: 2.80) with a consensus target price of $31.80 , a potential (32.89% upside)

    Analyst Ratings History For NxStage Medical, Inc. (NASDAQ:NXTM)

      with a price target of $24.00 to $30.00

    • On 12/11/2015 Sterne Agee CRT Initiated Coverage of rating Buy
    • On 5/5/2016 Wells Fargo & Company Reiterated Rating Sell
    • On 6/3/2016 Piper Jaffray Companies Reiterated Rating Buy with a price target of $21.00
    • On 5/4/2017 Northland Securities Downgraded rating Outperform to Market Perform
    • On 5/8/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $32.00
    • On 5/10/2017 BTIG Research Reiterated Rating Buy with a price target of $27.00

    Recent Trading Activity for NxStage Medical, Inc. (NASDAQ:NXTM)
    Shares of NxStage Medical, Inc. closed the previous trading session at 23.93 down -0.41 -1.68% with 289,243 shares trading hands.